Form preview

Get the free Form FDA 1571 - Investigational New Drug Application

Get Form
We are not affiliated with any brand or entity on this form
Illustration
Fill out
Complete the form online in a simple drag-and-drop editor.
Illustration
eSign
Add your legally binding signature or send the form for signing.
Illustration
Share
Share the form via a link, letting anyone fill it out from any device.
Illustration
Export
Download, print, email, or move the form to your cloud storage.

Why pdfFiller is the best tool for your documents and forms

GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

End-to-end document management

From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.

Accessible from anywhere

pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.

Secure and compliant

pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
Form preview

What is FDA 1571 IND

The Form FDA 1571 is a government document used by sponsors to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA).

pdfFiller scores top ratings on review platforms

Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Show more Show less
Fill fillable FDA 1571 IND form: Try Risk Free
Rate free FDA 1571 IND form
4.1
satisfied
44 votes

Who needs FDA 1571 IND?

Explore how professionals across industries use pdfFiller.
Picture
FDA 1571 IND is needed by:
  • Pharmaceutical companies looking to start clinical trials
  • Research institutions conducting drug development
  • Individual sponsors or representatives managing drug applications
  • Medical professionals involved in clinical investigations
  • Regulatory compliance officers ensuring submission accuracy

Comprehensive Guide to FDA 1571 IND

What is Form FDA 1571 - Investigational New Drug Application

Form FDA 1571, officially known as the Investigational New Drug Application (IND) form, serves as a critical component in the process of submitting IND applications. This document is utilized primarily by sponsors, which may include individuals or pharmaceutical companies, to obtain the necessary approvals from the U.S. Food and Drug Administration (FDA) for clinical investigations involving new drugs.
  • The primary purpose of Form FDA 1571 is to facilitate the review of new drug investigations.
  • It acts as a formal request for FDA authorization to begin clinical trials.
  • Typically, those responsible for completing this form are the sponsors or their authorized representatives.

Purpose and Benefits of the Form FDA 1571

Form FDA 1571 plays a crucial role in the drug development process by ensuring regulatory compliance and promoting patient safety. Obtaining FDA approval is indispensable for any new drug, and utilizing this specific form streamlines the process.
  • Using Form FDA 1571 helps sponsors navigate regulations effectively.
  • This form supports the facilitation of clinical trials, thus benefiting drug development timelines.
  • Ensuring patient safety during clinical trials is a fundamental benefit of this form.

Who Needs to Complete Form FDA 1571?

The completion of Form FDA 1571 typically involves multiple stakeholders. Understanding the roles of these individuals is essential for a smooth submission process.
  • The sponsor is the individual or organization responsible for the clinical investigation.
  • Authorized representatives act on behalf of the sponsor when completing the form.
  • Countersigners may be required to validate aspects of the application.
It is essential for each role to meet the specific requirements for signing the form to ensure its validity during the FDA submission process.

When and How to Submit the Form FDA 1571

Submitting Form FDA 1571 at the correct time is paramount for meeting regulatory deadlines. Sponsors must be aware of the various submission methods available.
  • Form FDA 1571 can be submitted online or via traditional mail.
  • Timing considerations include planning for review periods and required processing times.
  • Key submission deadlines must be tracked to ensure compliance with FDA regulations.

How to Fill Out Form FDA 1571 - Step-by-Step Guide

Completing Form FDA 1571 requires careful attention to detail. Here is a detailed guide to aid in correctly filling out the necessary fields.
  • Start by entering the sponsor's name and contact information in the designated fields.
  • Provide detailed drug information, including its classification and intended use.
  • Carefully review each section, ensuring all required fields are completed accurately.
Avoid common pitfalls, such as missing signatures or incomplete data, to ensure timely processing of your application.

Digital Signing and Submission Options for Form FDA 1571

Digital signing offers a convenient alternative to traditional methods for completing Form FDA 1571. Understanding the differences and security features associated with digital submission is essential.
  • Digital signatures differ from wet signatures in terms of verification processes.
  • Security measures, such as encryption, are vital when submitting the form online.
  • Using platforms like pdfFiller ensures a secure eSigning process.

Check Your Application Status After Submission

Once Form FDA 1571 is submitted, it's important to know how to track its status and address any inquiries that may arise.
  • Expect to receive notification regarding the status of your application after submission.
  • Track your application status through the FDA's official channels.
  • For inquiries, use the contact information provided during the submission process.

Security and Compliance with Form FDA 1571 Submissions

An emphasis on security and compliance is vital when submitting Form FDA 1571, especially since sensitive data is involved. Understanding protective measures can help alleviate concerns.
  • Encryption technology is utilized to safeguard data submitted through this form.
  • Compliance with legal standards ensures the privacy of sensitive information.
  • pdfFiller implements security protocols that enhance form submission safety.

Utilize pdfFiller to Complete Form FDA 1571 Efficiently

Using pdfFiller can greatly enhance your experience in completing Form FDA 1571. The platform provides several advantages for users managing their forms.
  • pdfFiller allows for easy editing, filling, and eSigning of forms online.
  • A cloud-based platform gives users the flexibility to access their forms from any location.
  • Storing and retrieving completed forms is simplified through pdfFiller's features.
Last updated on Feb 18, 2015

How to fill out the FDA 1571 IND

  1. 1.
    Access pdfFiller and locate the Form FDA 1571 by searching for the form name.
  2. 2.
    Once the form is open, familiarize yourself with the layout and required fields.
  3. 3.
    Gather all necessary information, such as your name, address, drug information, and clinical investigation details before starting to fill out the form.
  4. 4.
    Start filling in the fields systematically, entering the sponsor's name, address, and relevant drug information.
  5. 5.
    Proceed to complete the sections outlining the clinical investigation phases and submission details as accurately as possible.
  6. 6.
    If required, include details for the countersigner, ensuring all required signature fields are filled.
  7. 7.
    Use pdfFiller's features to review each entry for accuracy and completeness, double-checking against your gathered data.
  8. 8.
    Finalize the form by clicking the save option, then download it securely to your device.
  9. 9.
    If applicable, submit the form directly through pdfFiller or print it for mailing, according to submission guidelines.
Regular content decoration

FAQs

If you can't find what you're looking for, please contact us anytime!
The Form FDA 1571 is intended for sponsors of clinical investigations, which can include individuals, pharmaceutical companies, or organizations involved in developing new drugs.
While specific deadlines can vary, it is important to submit the Form FDA 1571 in a timely manner to initiate the drug review process, ideally at least 60 days before commencing clinical trials.
The completed Form FDA 1571 can be submitted online through pdfFiller's submission feature or printed for manual mailing to the FDA. Ensure to follow the submission guidelines provided by the FDA.
In addition to the completed Form FDA 1571, you may need to submit related documents such as an IND safety report, Clinical Investigator’s Brochure, or other data supporting your clinical investigation.
Common mistakes include leaving fields incomplete, not providing accurate drug or sponsor information, and failing to obtain necessary signatures, which could delay the submission process.
Processing times for IND applications can vary. Typically, the FDA reviews applications within 30 days, but additional time may be needed if further information is requested.
Currently, submission of the Form FDA 1571 has no application fees, but fees may apply for other related services or if the application involves certain categories of drugs.
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.